Bellevue Group Ag Portfolio Holdings

Bellevue Group Ag

  • $4.31 Billion
  • Q1 2025

Bellevue Group Ag has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $4.31 Billion distributed in 177 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $343M, Ionis Pharmaceuticals Inc with a value of $237M, Stryker Corp with a value of $211M, Intuitive Surgical Inc with a value of $211M, and Alnylam Pharmaceuticals, Inc. with a value of $207M.

Examining the 13F form we can see an decrease of $711M in the current position value, from $5.02B to 4.31B.

Bellevue Group Ag is based out at Kuesnacht, V8

Below you can find more details about Bellevue Group Ag portfolio as well as his latest detailed transactions.

Portfolio value $4.31 Billion
Healthcare: $4.3 Billion
ETFs: $4.83 Million
Technology: $500,000
Communication Services: $354,000
Consumer Cyclical: $171,000
Consumer Defensive: $104,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$22.4B
$725,000 0.02% of portfolio
7,964
Q1 2025 Reduced 4.42%
$2.81B
$722,000 0.02% of portfolio
20,000
Q1 2025 Added 53.85%
$128B
$887,000 0.02% of portfolio
16,000
Q1 2025 New
$1.86B
$809,000 0.02% of portfolio
81,740
Q1 2025 Reduced 11.28%
$767M
$1.03 Million 0.02% of portfolio
195,052
Q1 2025 Reduced 48.37%
$1.36B
$413,000 0.01% of portfolio
23,100
Q4 2024 Reduced 25.48%
$8.79B
$296,000 0.01% of portfolio
1,900
Q1 2025 Reduced 24.0%
$1.84B
$336,000 0.01% of portfolio
8,000
Q3 2024 Reduced 18.37%
$18.7B
$444,000 0.01% of portfolio
28,930
Q1 2025 Reduced 52.26%
$5B
$359,000 0.01% of portfolio
10,400
Q3 2024 Reduced 18.75%
$75.1B
$512,000 0.01% of portfolio
3,114
Q1 2025 Reduced 68.16%
$4.99B
$364,000 0.01% of portfolio
1,100
Q2 2024 Added 3.77%
$3.9B
$335,000 0.01% of portfolio
16,900
Q4 2024 Reduced 34.75%
$14.9B
$313,000 0.01% of portfolio
8,500
Q1 2025 New
$619M
$238,000 0.01% of portfolio
22,500
Q4 2024 New
$820M
$558,000 0.01% of portfolio
35,700
Q1 2025 Reduced 9.62%
$3.34B
$477,000 0.01% of portfolio
2,650
Q1 2025 Reduced 47.49%
$1.83B
$426,000 0.01% of portfolio
11,290
Q1 2025 Reduced 6.21%
$33.3B
$94,000 0.0% of portfolio
806
Q4 2024 Added 4.81%
Beta Bionics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
$2.09T
$171,000 0.0% of portfolio
900
Q1 2025 New
Tempus Ai Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 54.07%
$2.84B
$196,000 0.0% of portfolio
3,000
Q4 2024 Reduced 25.0%
$8.7B
$104,000 0.0% of portfolio
1,400
Q1 2025 New
$30.8B
$184,000 0.0% of portfolio
2,000
Q1 2024 New
Waystar Hldg Corp
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 8.53%
$957B
$170,000 0.0% of portfolio
1,100
Q1 2025 New
$17.8B
$55,000 0.0% of portfolio
402
Q1 2025 Reduced 84.84%
Oculis Holding Ag
-
$0 0.0% of portfolio
-
Q1 2025 Added 41.0%
$336B
$81,000 0.0% of portfolio
751
Q4 2024 Added 4.89%
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 12.8%
$1.48B
$117,000 0.0% of portfolio
3,000
Q1 2025 Reduced 31.82%
Kestra Med Technologies LTD
-
$0 0.0% of portfolio
-
Q1 2025 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 5.71%
$3.38T
$76,000 0.0% of portfolio
203
Q4 2024 Added 4.64%
$25.7B
$49,000 0.0% of portfolio
42
Q4 2024 Added 2.44%
$430B
$91,000 0.0% of portfolio
654
Q4 2024 Added 4.81%
Ge Healthcare Technologies I
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 1.42%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 54.29%
Biohaven LTD
-
$0 0.0% of portfolio
-
Q2 2024 Added 77.47%
Brightspring Health Svcs Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 38.81%
$3.24B
$193,000 0.0% of portfolio
3,800
Q4 2024 New
Cooper Cos Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 0.03%
$2.81B
$150,000 0.0% of portfolio
3,741
Q1 2025 Reduced 65.81%
$171B
$68,000 0.0% of portfolio
447
Q4 2024 Added 4.68%
$38.7B
$184,000 0.0% of portfolio
850
Q1 2025 Reduced 19.05%
Labcorp Holdings Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 12,928.24%

Summary

  • Portfolio
  • No. of Stocks 177
  • Current Value $4.31 Billion
  • Prior Value $5.02 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 10 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 81 stocks
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email